CIRS will feature a variety of quality assurance (QA), research and training phantoms for all radiology imaging modalities at the 2014 Radiological Society of North America (RSNA) meeting, held Nov. 30-Dec. 3 in Chicago.

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment followed the standard 12 month protocol. This was according to data from the DAPT (Dual Antiplatelet Therapy) Study, a key late-breaking clinical trial presented at the American Heart Association’s Scientific Sessions 2014 this week.
Covidien plc (NYSE: COV) announced results of the durability Iliac study and addition of the iliac indication for its EverFlex stent at the Vascular Interventional Advances (VIVA) 2014 conference.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Radcal Corporation announced the release of its first WiFi device, the Nugget, which will be unveiled at the 2014 RSNA trade show, along with the new Accu-Dose+ ion chamber based diagnostic meter, Accu-Gold, to replace the legacy dose meters.
Pierre Galvagni Silveira, M.D., Ph.D. enrolled the first two patients in the Gore Thoracoabdominal Aortic Aneurysm Clinical Study. This initial feasibility study of the Gore Excluder Thoracoabdominal Branch Endoprosthesis will assess the safety of the device implantation procedure in the treatment of abdominal aortic aneurysms encroaching on or involving visceral branch vessels.
VIVA Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announced late-breaking clinical trial results VIVA 14, an annual multidisciplinary vascular education conference hosted in Las Vegas.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
AccentHealth will collaborate with the American Heart Association/American Stroke Association (AHA/ASA) to provide expert content to viewers of its television network in doctor offices' waiting rooms. This content will cover key cardiovascular health topics such as healthy living, stroke and high blood pressure.
The Journal of the American College of Cardiology collection launches JACC: Clinical Electrophysiology, which will feature research and review articles regarding cardiac rhythm disorders. David J. Wilber, M.D., FACC, will serve as editor-in-chief of the new journal, which will begin publishing in March 2015 on a bimonthly basis.
Siemens Healthcare has introduced the Symbia Evo Excel SPECT (single-photon emission computed tomography) system—a new version of the company’s Symbia E system that combines SPECT image resolution and detector sensitivity with the smallest room size requirement in its class.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Boston Scientific Corp. announced that its subcutaneous implantable defibrillator (S-ICD System) will have designated Current Procedural Terminology (CPT) Category I codes by the American Medical Association (AMA), effective Jan. 1, 2015.
The American College of Cardiology (ACC), which has been developing clinical practice guidelines in partnership with the American Heart Association (AHA) for more than three decades, has launched a new Guideline Clinical App to serve as the mobile home for all ACC/AHA guideline content and related tools.
Philips Healthcare is introducing its latest mobile c-arm imaging system. The Veradius Unity is uses a thin flat digital detector instead of an image intensifier and offers several features to aid procedural guidance and enhance the user interface.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Covidien releases 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical benefits of plaque removal using directional atherectomy followed by drug-coated balloon. The results were presented by Professor Thomas Zeller of the Universitaets-Herzzentrum, Bad Krozingen, Germany at the Vascular Interventional Advances (VIVA) 2014 conference in Las Vegas, Nev.
Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES). In support of this strategy, the company has entered into a five-year agreement with Stentys as an exclusive worldwide distributor of the MiStent SES, except in the United States, Canada, China, South Korea and Japan. Stentys plans to launch MiStent in the first half of 2015 in Europe, followed by many other geographies where they have built a commercial network
ClearFlow Inc. announced positive results from the Prevention of Retained Blood Outcomes Using Active Clearance Technology trial (PRO-ACT), a clinical study evaluating the use of PleuraFlow Active Clearance Technology System to prevent retained blood complications.